Share Price and Basic Stock Data
Last Updated: April 3, 2025, 1:53 am
PEG Ratio | 8.34 |
---|
Competitors of Hindustan Unilever Ltd
Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
---|---|---|---|---|---|---|---|---|---|
Honasa Consumer Ltd | 7,677 Cr. | 236 | 547/197 | 113 | 35.5 | 0.00 % | 17.1 % | % | 10.0 |
Ambica Agarbathies Aroma & Industries Ltd | 46.3 Cr. | 27.4 | 37.0/23.2 | 17.5 | 60.6 | 0.00 % | 5.07 % | 3.65 % | 10.0 |
Ador Multi Products Ltd | 34.4 Cr. | 73.7 | 73.9/23.4 | 23.2 | 0.00 % | 33.6 % | 26.7 % | 10.0 | |
Kaya Ltd | 317 Cr. | 241 | 702/213 | 106 | 0.00 % | 80.4 % | % | 10.0 | |
Jyothy Labs Ltd | 12,289 Cr. | 335 | 596/310 | 33.0 | 51.4 | 1.05 % | 27.0 % | 21.2 % | 1.00 |
Industry Average | 68,311.50 Cr | 1,932.94 | 48.15 | 109.30 | 0.80% | 36.43% | 29.37% | 4.94 |
Quarterly Result
Metric | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 13,439 | 13,767 | 14,624 | 15,144 | 15,597 | 15,215 | 15,496 | 15,623 | 15,567 | 15,210 | 15,707 | 15,926 | 15,818 |
Expenses | 10,030 | 10,466 | 11,222 | 11,665 | 11,903 | 11,643 | 11,832 | 11,828 | 11,902 | 11,675 | 11,965 | 12,139 | 12,123 |
Operating Profit | 3,409 | 3,301 | 3,402 | 3,479 | 3,694 | 3,572 | 3,664 | 3,795 | 3,665 | 3,535 | 3,742 | 3,787 | 3,695 |
OPM % | 25% | 24% | 23% | 23% | 24% | 23% | 24% | 24% | 24% | 23% | 24% | 24% | 23% |
Other Income | -7 | 136 | 121 | 80 | 7 | 240 | 146 | 178 | 184 | 309 | 209 | 203 | 740 |
Interest | 27 | 38 | 28 | 28 | 29 | 29 | 50 | 88 | 91 | 105 | 93 | 110 | 112 |
Depreciation | 272 | 278 | 281 | 272 | 293 | 291 | 286 | 297 | 313 | 320 | 329 | 338 | 341 |
Profit before tax | 3,103 | 3,121 | 3,214 | 3,259 | 3,379 | 3,492 | 3,474 | 3,588 | 3,445 | 3,419 | 3,529 | 3,542 | 3,982 |
Tax % | 26% | 26% | 26% | 18% | 27% | 26% | 26% | 26% | 27% | 25% | 26% | 27% | 25% |
Net Profit | 2,300 | 2,307 | 2,391 | 2,670 | 2,481 | 2,601 | 2,556 | 2,657 | 2,508 | 2,561 | 2,612 | 2,595 | 2,989 |
EPS in Rs | 9.78 | 9.81 | 10.13 | 11.34 | 10.53 | 11.07 | 10.87 | 11.30 | 10.68 | 10.89 | 11.11 | 11.03 | 12.70 |
Last Updated: March 3, 2025, 5:55 pm
Below is a detailed analysis of the quarterly data for Hindustan Unilever Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:
- For Sales, as of Dec 2024, the value is ₹15,818.00 Cr.. The value appears to be declining and may need further review. It has decreased from 15,926.00 Cr. (Sep 2024) to ₹15,818.00 Cr., marking a decrease of 108.00 Cr..
- For Expenses, as of Dec 2024, the value is ₹12,123.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 12,139.00 Cr. (Sep 2024) to ₹12,123.00 Cr., marking a decrease of 16.00 Cr..
- For Operating Profit, as of Dec 2024, the value is ₹3,695.00 Cr.. The value appears to be declining and may need further review. It has decreased from 3,787.00 Cr. (Sep 2024) to ₹3,695.00 Cr., marking a decrease of 92.00 Cr..
- For OPM %, as of Dec 2024, the value is 23.00%. The value appears to be declining and may need further review. It has decreased from 24.00% (Sep 2024) to 23.00%, marking a decrease of 1.00%.
- For Other Income, as of Dec 2024, the value is ₹740.00 Cr.. The value appears strong and on an upward trend. It has increased from 203.00 Cr. (Sep 2024) to ₹740.00 Cr., marking an increase of 537.00 Cr..
- For Interest, as of Dec 2024, the value is ₹112.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 110.00 Cr. (Sep 2024) to ₹112.00 Cr., marking an increase of 2.00 Cr..
- For Depreciation, as of Dec 2024, the value is ₹341.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 338.00 Cr. (Sep 2024) to ₹341.00 Cr., marking an increase of 3.00 Cr..
- For Profit before tax, as of Dec 2024, the value is ₹3,982.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,542.00 Cr. (Sep 2024) to ₹3,982.00 Cr., marking an increase of 440.00 Cr..
- For Tax %, as of Dec 2024, the value is 25.00%. The value appears to be improving (decreasing) as expected. It has decreased from 27.00% (Sep 2024) to 25.00%, marking a decrease of 2.00%.
- For Net Profit, as of Dec 2024, the value is ₹2,989.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,595.00 Cr. (Sep 2024) to ₹2,989.00 Cr., marking an increase of 394.00 Cr..
- For EPS in Rs, as of Dec 2024, the value is 12.70. The value appears strong and on an upward trend. It has increased from 11.03 (Sep 2024) to 12.70, marking an increase of 1.67.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: March 7, 2025, 9:29 pm
Metric | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 27,004 | 29,234 | 31,972 | 32,186 | 33,162 | 35,545 | 39,310 | 39,783 | 47,028 | 52,446 | 60,580 | 61,896 | 62,661 |
Expenses | 22,784 | 24,475 | 26,560 | 26,276 | 26,834 | 28,046 | 30,430 | 29,922 | 35,402 | 39,589 | 46,433 | 47,237 | 47,902 |
Operating Profit | 4,220 | 4,759 | 5,412 | 5,910 | 6,328 | 7,499 | 8,880 | 9,861 | 11,626 | 12,857 | 14,147 | 14,659 | 14,759 |
OPM % | 16% | 16% | 17% | 18% | 19% | 21% | 23% | 25% | 25% | 25% | 23% | 24% | 24% |
Other Income | 1,123 | 792 | 1,247 | 486 | 606 | 353 | 322 | 424 | 170 | 219 | 448 | 817 | 1,461 |
Interest | 26 | 41 | 18 | 17 | 35 | 26 | 33 | 118 | 117 | 106 | 114 | 334 | 420 |
Depreciation | 251 | 296 | 322 | 353 | 432 | 520 | 565 | 1,002 | 1,074 | 1,091 | 1,137 | 1,216 | 1,328 |
Profit before tax | 5,066 | 5,215 | 6,320 | 6,026 | 6,467 | 7,306 | 8,604 | 9,165 | 10,605 | 11,879 | 13,344 | 13,926 | 14,472 |
Tax % | 24% | 24% | 31% | 31% | 31% | 28% | 30% | 26% | 25% | 25% | 24% | 26% | |
Net Profit | 3,839 | 3,956 | 4,376 | 4,151 | 4,490 | 5,227 | 6,060 | 6,756 | 7,999 | 8,892 | 10,143 | 10,282 | 10,757 |
EPS in Rs | 17.71 | 18.24 | 20.17 | 19.18 | 20.68 | 24.09 | 27.97 | 31.17 | 34.03 | 37.79 | 43.07 | 43.74 | 45.73 |
Dividend Payout % | 104% | 71% | 74% | 83% | 82% | 83% | 78% | 80% | 119% | 90% | 91% | 96% |
YoY Net Profit Growth
Year | 2013-2014 | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 |
---|---|---|---|---|---|---|---|---|---|---|---|
YoY Net Profit Growth (%) | 3.05% | 10.62% | -5.14% | 8.17% | 16.41% | 15.94% | 11.49% | 18.40% | 11.16% | 14.07% | 1.37% |
Change in YoY Net Profit Growth (%) | 0.00% | 7.57% | -15.76% | 13.31% | 8.25% | -0.48% | -4.45% | 6.91% | -7.23% | 2.90% | -12.70% |
Hindustan Unilever Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2013-2014 to 2023-2024.
Growth
Compounded Sales Growth | |
---|---|
10 Years: | 8% |
5 Years: | 10% |
3 Years: | 10% |
TTM: | 1% |
Compounded Profit Growth | |
---|---|
10 Years: | 11% |
5 Years: | 11% |
3 Years: | 8% |
TTM: | 0% |
Stock Price CAGR | |
---|---|
10 Years: | 9% |
5 Years: | 1% |
3 Years: | 2% |
1 Year: | -1% |
Return on Equity | |
---|---|
10 Years: | 32% |
5 Years: | 24% |
3 Years: | 20% |
Last Year: | 20% |
Last Updated: Unknown
Balance Sheet
Last Updated: November 15, 2024, 1:50 am
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 216 | 216 | 216 | 216 | 216 | 216 | 216 | 216 | 235 | 235 | 235 | 235 | 235 |
Reserves | 2,649 | 3,321 | 3,811 | 6,357 | 6,528 | 7,065 | 7,651 | 8,013 | 47,439 | 48,826 | 50,069 | 50,983 | 50,541 |
Borrowings | 25 | 46 | 43 | 177 | 277 | 0 | 99 | 0 | 0 | 1,043 | 1,219 | 1,484 | 1,651 |
Other Liabilities | 9,202 | 10,171 | 10,359 | 8,043 | 8,685 | 10,581 | 10,663 | 11,924 | 21,066 | 20,402 | 21,554 | 25,787 | 28,338 |
Total Liabilities | 12,092 | 13,754 | 14,430 | 14,793 | 15,706 | 17,862 | 18,629 | 20,153 | 68,740 | 70,506 | 73,077 | 78,489 | 80,765 |
Fixed Assets | 2,431 | 2,746 | 2,821 | 3,258 | 4,419 | 4,528 | 4,715 | 5,479 | 51,443 | 51,473 | 52,678 | 53,744 | 54,027 |
CWIP | 222 | 373 | 516 | 408 | 229 | 461 | 406 | 597 | 745 | 1,313 | 1,132 | 1,025 | 1,022 |
Investments | 2,252 | 2,838 | 3,025 | 2,592 | 3,794 | 2,873 | 2,716 | 1,255 | 2,709 | 3,521 | 2,882 | 4,625 | 4,316 |
Other Assets | 7,186 | 7,797 | 8,067 | 8,535 | 7,264 | 10,000 | 10,792 | 12,822 | 13,843 | 14,199 | 16,385 | 19,095 | 21,400 |
Total Assets | 12,092 | 13,754 | 14,430 | 14,793 | 15,706 | 17,862 | 18,629 | 20,153 | 68,740 | 70,506 | 73,077 | 78,489 | 80,765 |
Below is a detailed analysis of the balance sheet data for Hindustan Unilever Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2024, the value is ₹235.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 235.00 Cr..
- For Reserves, as of Sep 2024, the value is ₹50,541.00 Cr.. The value appears to be declining and may need further review. It has decreased from 50,983.00 Cr. (Mar 2024) to ₹50,541.00 Cr., marking a decrease of 442.00 Cr..
- For Borrowings, as of Sep 2024, the value is ₹1,651.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 1,484.00 Cr. (Mar 2024) to ₹1,651.00 Cr., marking an increase of 167.00 Cr..
- For Other Liabilities, as of Sep 2024, the value is ₹28,338.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 25,787.00 Cr. (Mar 2024) to ₹28,338.00 Cr., marking an increase of 2,551.00 Cr..
- For Total Liabilities, as of Sep 2024, the value is ₹80,765.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 78,489.00 Cr. (Mar 2024) to ₹80,765.00 Cr., marking an increase of 2,276.00 Cr..
- For Fixed Assets, as of Sep 2024, the value is ₹54,027.00 Cr.. The value appears strong and on an upward trend. It has increased from 53,744.00 Cr. (Mar 2024) to ₹54,027.00 Cr., marking an increase of 283.00 Cr..
- For CWIP, as of Sep 2024, the value is ₹1,022.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,025.00 Cr. (Mar 2024) to ₹1,022.00 Cr., marking a decrease of 3.00 Cr..
- For Investments, as of Sep 2024, the value is ₹4,316.00 Cr.. The value appears to be declining and may need further review. It has decreased from 4,625.00 Cr. (Mar 2024) to ₹4,316.00 Cr., marking a decrease of 309.00 Cr..
- For Other Assets, as of Sep 2024, the value is ₹21,400.00 Cr.. The value appears strong and on an upward trend. It has increased from 19,095.00 Cr. (Mar 2024) to ₹21,400.00 Cr., marking an increase of 2,305.00 Cr..
- For Total Assets, as of Sep 2024, the value is ₹80,765.00 Cr.. The value appears strong and on an upward trend. It has increased from 78,489.00 Cr. (Mar 2024) to ₹80,765.00 Cr., marking an increase of 2,276.00 Cr..
Notably, the Reserves (₹50,541.00 Cr.) exceed the Borrowings (1,651.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow | -21.00 | -42.00 | -38.00 | -172.00 | -271.00 | 7.00 | -91.00 | 9.00 | 11.00 | 11.00 | 13.00 | 13.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 13 | 13 | 12 | 14 | 12 | 13 | 17 | 11 | 14 | 16 | 19 | 18 |
Inventory Days | 83 | 86 | 77 | 75 | 67 | 65 | 59 | 65 | 66 | 65 | 55 | 55 |
Days Payable | 164 | 170 | 148 | 156 | 164 | 185 | 166 | 176 | 163 | 145 | 123 | 143 |
Cash Conversion Cycle | -67 | -72 | -60 | -67 | -85 | -107 | -90 | -101 | -83 | -64 | -50 | -70 |
Working Capital Days | -49 | -54 | -52 | -24 | -32 | -37 | -29 | -31 | -32 | -20 | -13 | -19 |
ROCE % | 130% | 147% | 139% | 112% | 91% | 103% | 116% | 117% | 39% | 25% | 27% | 27% |
Mutual Fund Holdings
Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
---|---|---|---|---|---|---|
SBI Nifty 50 ETF | 16,489,465 | 2.21 | 4580.77 | 3,217,964 | 2025-04-02 | 412.42% |
SBI BSE Sensex ETF | 11,802,512 | 2.62 | 3278.86 | 3,217,964 | 2025-04-02 | 266.77% |
ICICI Prudential Value Discovery Fund | 5,658,246 | 3.13 | 1571.86 | 3,217,964 | 2025-04-02 | 75.83% |
UTI Nifty 50 ETF | 4,782,594 | 2.21 | 1328.6 | 3,217,964 | 2025-04-02 | 48.62% |
SBI Blue Chip Fund | 4,590,000 | 2.47 | 1275.1 | 3,217,964 | 2025-04-02 | 42.64% |
UTI BSE Sensex ETF | 4,364,862 | 2.62 | 1212.6 | 3,217,964 | 2025-04-02 | 35.64% |
ICICI Prudential Balanced Advantage Fund | 3,217,964 | 1.46 | 893.95 | 3,217,964 | 2025-04-02 | 0% |
Nippon India ETF Nifty 50 BeES | 2,606,174 | 2.21 | 724 | 3,217,964 | 2025-04-02 | -19.01% |
Kotak Flexicap Fund - Regular Plan | 2,600,000 | 1.36 | 722.28 | 3,217,964 | 2025-04-02 | -19.2% |
Mirae Asset Large Cap Fund | 2,315,497 | 1.55 | 643.25 | 3,217,964 | 2025-04-02 | -28.04% |
Key Financial Ratios
Month | Mar 24 | Mar 23 | Mar 22 | Mar 21 | Mar 20 |
---|---|---|---|---|---|
FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Basic EPS (Rs.) | 43.74 | 43.07 | 37.79 | 34.03 | 31.17 |
Diluted EPS (Rs.) | 43.74 | 43.07 | 37.79 | 34.03 | 31.17 |
Cash EPS (Rs.) | 48.94 | 48.00 | 42.48 | 38.61 | 35.92 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 218.82 | 214.99 | 208.88 | 202.95 | 38.18 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 218.82 | 214.99 | 208.88 | 202.95 | 38.18 |
Revenue From Operations / Share (Rs.) | 263.39 | 257.79 | 223.17 | 200.12 | 184.18 |
PBDIT / Share (Rs.) | 65.85 | 62.39 | 55.81 | 51.22 | 48.58 |
PBIT / Share (Rs.) | 60.67 | 57.55 | 51.17 | 46.65 | 43.94 |
PBT / Share (Rs.) | 59.28 | 56.79 | 50.53 | 45.13 | 42.47 |
Net Profit / Share (Rs.) | 43.77 | 43.17 | 37.84 | 34.04 | 31.28 |
NP After MI And SOA / Share (Rs.) | 43.73 | 43.06 | 37.78 | 34.02 | 31.24 |
PBDIT Margin (%) | 25.00 | 24.20 | 25.00 | 25.59 | 26.37 |
PBIT Margin (%) | 23.03 | 22.32 | 22.92 | 23.30 | 23.85 |
PBT Margin (%) | 22.50 | 22.03 | 22.64 | 22.55 | 23.05 |
Net Profit Margin (%) | 16.61 | 16.74 | 16.95 | 17.00 | 16.98 |
NP After MI And SOA Margin (%) | 16.60 | 16.70 | 16.92 | 17.00 | 16.96 |
Return on Networth / Equity (%) | 20.06 | 20.11 | 18.09 | 16.77 | 82.00 |
Return on Capital Employeed (%) | 21.72 | 22.14 | 20.29 | 19.01 | 87.58 |
Return On Assets (%) | 13.09 | 13.84 | 12.59 | 11.62 | 33.48 |
Asset Turnover Ratio (%) | 0.81 | 0.83 | 0.73 | 1.04 | 2.03 |
Current Ratio (X) | 1.66 | 1.41 | 1.38 | 1.28 | 1.32 |
Quick Ratio (X) | 1.34 | 1.06 | 1.01 | 0.95 | 1.03 |
Inventory Turnover Ratio (X) | 4.66 | 4.73 | 4.25 | 4.86 | 4.44 |
Dividend Payout Ratio (NP) (%) | 91.44 | 83.58 | 84.68 | 110.20 | 77.00 |
Dividend Payout Ratio (CP) (%) | 81.77 | 75.14 | 75.41 | 97.15 | 67.04 |
Earning Retention Ratio (%) | 8.56 | 16.42 | 15.32 | -10.20 | 23.00 |
Cash Earning Retention Ratio (%) | 18.23 | 24.86 | 24.59 | 2.85 | 32.96 |
Interest Coverage Ratio (X) | 46.33 | 128.61 | 123.73 | 102.87 | 88.92 |
Interest Coverage Ratio (Post Tax) (X) | 31.78 | 90.55 | 85.25 | 71.42 | 60.02 |
Enterprise Value (Cr.) | 525697.75 | 596944.25 | 477659.75 | 566787.00 | 491304.40 |
EV / Net Operating Revenue (X) | 8.49 | 9.85 | 9.11 | 12.05 | 12.35 |
EV / EBITDA (X) | 33.97 | 40.72 | 36.42 | 47.09 | 46.82 |
MarketCap / Net Operating Revenue (X) | 8.61 | 9.93 | 9.18 | 12.15 | 12.48 |
Retention Ratios (%) | 8.55 | 16.41 | 15.31 | -10.20 | 22.99 |
Price / BV (X) | 10.41 | 11.95 | 9.81 | 11.98 | 60.32 |
Price / Net Operating Revenue (X) | 8.61 | 9.93 | 9.18 | 12.15 | 12.48 |
EarningsYield | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
After reviewing the key financial ratios for Hindustan Unilever Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 24, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 24, the value is 43.74. This value is within the healthy range. It has increased from 43.07 (Mar 23) to 43.74, marking an increase of 0.67.
- For Diluted EPS (Rs.), as of Mar 24, the value is 43.74. This value is within the healthy range. It has increased from 43.07 (Mar 23) to 43.74, marking an increase of 0.67.
- For Cash EPS (Rs.), as of Mar 24, the value is 48.94. This value is within the healthy range. It has increased from 48.00 (Mar 23) to 48.94, marking an increase of 0.94.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 218.82. It has increased from 214.99 (Mar 23) to 218.82, marking an increase of 3.83.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 218.82. It has increased from 214.99 (Mar 23) to 218.82, marking an increase of 3.83.
- For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 263.39. It has increased from 257.79 (Mar 23) to 263.39, marking an increase of 5.60.
- For PBDIT / Share (Rs.), as of Mar 24, the value is 65.85. This value is within the healthy range. It has increased from 62.39 (Mar 23) to 65.85, marking an increase of 3.46.
- For PBIT / Share (Rs.), as of Mar 24, the value is 60.67. This value is within the healthy range. It has increased from 57.55 (Mar 23) to 60.67, marking an increase of 3.12.
- For PBT / Share (Rs.), as of Mar 24, the value is 59.28. This value is within the healthy range. It has increased from 56.79 (Mar 23) to 59.28, marking an increase of 2.49.
- For Net Profit / Share (Rs.), as of Mar 24, the value is 43.77. This value is within the healthy range. It has increased from 43.17 (Mar 23) to 43.77, marking an increase of 0.60.
- For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 43.73. This value is within the healthy range. It has increased from 43.06 (Mar 23) to 43.73, marking an increase of 0.67.
- For PBDIT Margin (%), as of Mar 24, the value is 25.00. This value is within the healthy range. It has increased from 24.20 (Mar 23) to 25.00, marking an increase of 0.80.
- For PBIT Margin (%), as of Mar 24, the value is 23.03. This value exceeds the healthy maximum of 20. It has increased from 22.32 (Mar 23) to 23.03, marking an increase of 0.71.
- For PBT Margin (%), as of Mar 24, the value is 22.50. This value is within the healthy range. It has increased from 22.03 (Mar 23) to 22.50, marking an increase of 0.47.
- For Net Profit Margin (%), as of Mar 24, the value is 16.61. This value exceeds the healthy maximum of 10. It has decreased from 16.74 (Mar 23) to 16.61, marking a decrease of 0.13.
- For NP After MI And SOA Margin (%), as of Mar 24, the value is 16.60. This value is within the healthy range. It has decreased from 16.70 (Mar 23) to 16.60, marking a decrease of 0.10.
- For Return on Networth / Equity (%), as of Mar 24, the value is 20.06. This value is within the healthy range. It has decreased from 20.11 (Mar 23) to 20.06, marking a decrease of 0.05.
- For Return on Capital Employeed (%), as of Mar 24, the value is 21.72. This value is within the healthy range. It has decreased from 22.14 (Mar 23) to 21.72, marking a decrease of 0.42.
- For Return On Assets (%), as of Mar 24, the value is 13.09. This value is within the healthy range. It has decreased from 13.84 (Mar 23) to 13.09, marking a decrease of 0.75.
- For Asset Turnover Ratio (%), as of Mar 24, the value is 0.81. It has decreased from 0.83 (Mar 23) to 0.81, marking a decrease of 0.02.
- For Current Ratio (X), as of Mar 24, the value is 1.66. This value is within the healthy range. It has increased from 1.41 (Mar 23) to 1.66, marking an increase of 0.25.
- For Quick Ratio (X), as of Mar 24, the value is 1.34. This value is within the healthy range. It has increased from 1.06 (Mar 23) to 1.34, marking an increase of 0.28.
- For Inventory Turnover Ratio (X), as of Mar 24, the value is 4.66. This value is within the healthy range. It has decreased from 4.73 (Mar 23) to 4.66, marking a decrease of 0.07.
- For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 91.44. This value exceeds the healthy maximum of 50. It has increased from 83.58 (Mar 23) to 91.44, marking an increase of 7.86.
- For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 81.77. This value exceeds the healthy maximum of 50. It has increased from 75.14 (Mar 23) to 81.77, marking an increase of 6.63.
- For Earning Retention Ratio (%), as of Mar 24, the value is 8.56. This value is below the healthy minimum of 40. It has decreased from 16.42 (Mar 23) to 8.56, marking a decrease of 7.86.
- For Cash Earning Retention Ratio (%), as of Mar 24, the value is 18.23. This value is below the healthy minimum of 40. It has decreased from 24.86 (Mar 23) to 18.23, marking a decrease of 6.63.
- For Interest Coverage Ratio (X), as of Mar 24, the value is 46.33. This value is within the healthy range. It has decreased from 128.61 (Mar 23) to 46.33, marking a decrease of 82.28.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 31.78. This value is within the healthy range. It has decreased from 90.55 (Mar 23) to 31.78, marking a decrease of 58.77.
- For Enterprise Value (Cr.), as of Mar 24, the value is 525,697.75. It has decreased from 596,944.25 (Mar 23) to 525,697.75, marking a decrease of 71,246.50.
- For EV / Net Operating Revenue (X), as of Mar 24, the value is 8.49. This value exceeds the healthy maximum of 3. It has decreased from 9.85 (Mar 23) to 8.49, marking a decrease of 1.36.
- For EV / EBITDA (X), as of Mar 24, the value is 33.97. This value exceeds the healthy maximum of 15. It has decreased from 40.72 (Mar 23) to 33.97, marking a decrease of 6.75.
- For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 8.61. This value exceeds the healthy maximum of 3. It has decreased from 9.93 (Mar 23) to 8.61, marking a decrease of 1.32.
- For Retention Ratios (%), as of Mar 24, the value is 8.55. This value is below the healthy minimum of 30. It has decreased from 16.41 (Mar 23) to 8.55, marking a decrease of 7.86.
- For Price / BV (X), as of Mar 24, the value is 10.41. This value exceeds the healthy maximum of 3. It has decreased from 11.95 (Mar 23) to 10.41, marking a decrease of 1.54.
- For Price / Net Operating Revenue (X), as of Mar 24, the value is 8.61. This value exceeds the healthy maximum of 3. It has decreased from 9.93 (Mar 23) to 8.61, marking a decrease of 1.32.
- For EarningsYield, as of Mar 24, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 23) which recorded 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Strength | Weakness |
---|---|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Hindustan Unilever Ltd:
- Net Profit Margin: 16.61%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 21.72% (Industry Average ROCE: 36.43%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 20.06% (Industry Average ROE: 29.37%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 31.78
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.34
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 50.8 (Industry average Stock P/E: 48.15)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 16.61%
About the Company - Qualitative Analysis
INDUSTRY | ADDRESS | CONTACT |
---|---|---|
Personal Care | Unilever House, B D Sawant Marg, Mumbai Maharashtra 400099 | levercare.shareholder@unilever.com http://www.hul.co.in |
Management | |
---|---|
Name | Position Held |
Mr. Nitin Paranjpe | Chairman & Non-Exe.Director |
Mr. Rohit Jawa | Managing Director & CEO |
Mr. Ritesh Tiwari | Executive Director & CFO |
Mr. Dev Bajpai | Executive Director |
Mr. O P Bhatt | Independent Director |
Mr. Leo Puri | Independent Director |
Mr. Sanjiv Mehta | Independent Director |
Ms. Kalpana Morparia | Independent Director |
Ms. Ashu Suyash | Independent Director |
Mr. Ranjay Gulati | Independent Director |
Ms. Neelam Dhawan | Independent Director |
Mr. Tarun Bajaj | Independent Director |
FAQ
What is the intrinsic value of Hindustan Unilever Ltd?
Hindustan Unilever Ltd's intrinsic value (as of 03 April 2025) is ₹1806.54 — 19.28% lower the current market price of ₹2,238.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 5,25,862 Cr. market cap, FY2025-2026 high/low of ₹3,035/2,136, reserves of 50,541 Cr, and liabilities of 80,765 Cr.
What is the Market Cap of Hindustan Unilever Ltd?
The Market Cap of Hindustan Unilever Ltd is 5,25,862 Cr..
What is the current Stock Price of Hindustan Unilever Ltd as on 03 April 2025?
The current stock price of Hindustan Unilever Ltd as on 03 April 2025 is 2,238.
What is the High / Low of Hindustan Unilever Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Hindustan Unilever Ltd stocks is ₹3,035/2,136.
What is the Stock P/E of Hindustan Unilever Ltd?
The Stock P/E of Hindustan Unilever Ltd is 50.8.
What is the Book Value of Hindustan Unilever Ltd?
The Book Value of Hindustan Unilever Ltd is 216.
What is the Dividend Yield of Hindustan Unilever Ltd?
The Dividend Yield of Hindustan Unilever Ltd is 1.88 %.
What is the ROCE of Hindustan Unilever Ltd?
The ROCE of Hindustan Unilever Ltd is 27.2 %.
What is the ROE of Hindustan Unilever Ltd?
The ROE of Hindustan Unilever Ltd is 20.2 %.
What is the Face Value of Hindustan Unilever Ltd?
The Face Value of Hindustan Unilever Ltd is 1.00.